CVE-2018-14786

high-risk
Published 2018-08-23

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

Do I need to act?

~
7.3% chance of exploitation in next 30 days
EPSS score — moderate exploit probability
-
Not on CISA KEV list
No confirmed active exploitation reported to CISA
?
Patch status unknown
Check vendor advisories for fix availability and mitigation guidance
9
CVSS 9.4/10 Critical
NETWORK / LOW complexity

Affected Products (4)

Alaris Gs Firmware
Alaris Gh Firmware
Alaris Cc Firmware
Alaris Tiva Firmware

Affected Vendors

Bd

References (6)

Vendor Advisory http://www.bd.com/en-us/support/product-security-and-privacy/product-security-bu...
Third Party Advisory http://www.securityfocus.com/bid/105147
Third Party Advisory https://ics-cert.us-cert.gov/advisories/ICSMA-18-235-01
Vendor Advisory http://www.bd.com/en-us/support/product-security-and-privacy/product-security-bu...
Third Party Advisory http://www.securityfocus.com/bid/105147
Third Party Advisory https://ics-cert.us-cert.gov/advisories/ICSMA-18-235-01
51
/ 100
high-risk
Severity 31/34 · Critical
Exploitability 10/34 · Low
Exposure 10/34 · Low